RK

Rajesh Kumar Jain

Director Director DIN 07891688
DIN 07891688 First appointment Sep 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Kumar Jain

Data last updated:

Rajesh Kumar Jain was a Director at Imaec Limited (2018–2020) and Director at Code Medipharma Private Limited (from 2017). The companies operate in Healthcare.

DIN 07891688
Primary Designation Director
Industry Healthcare
First Appointment 09 Sep 2017
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Imaec Limited U80301MH2007PLC174724
Director16 Jan 20182007₹1.83 Cr (FY 2025)Active
Code Medipharma Private Limited U74999MH2016PTC286652
Director09 Sep 20172016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Code Medipharma Private Limited
Imaec Limited
Premium access

Shareholding and investment profile for Rajesh Kumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar Jain

Rajesh Kumar Jain was first appointed on 09 Sep 2017 as Director at Code Medipharma Private Limited. The most recent appointment on record is 16 Jan 2018 at Imaec Limited.

Rajesh Kumar Jain held 2 earlier board appointments: Imaec Limited (Director, 16 Jan 2018 to 11 Dec 2020); Code Medipharma Private Limited (Director, from 09 Sep 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available